Serum thyroglobulin concentrations are used to monitor patients with differentiated thyroid cancer, but may be misleading in the presence of antithyroglobulin autoantibodies and heterophile antibodies. Mayo Medical Laboratories has developed an assay to address this issue by testing first for the presence of thyroglobulin antibodies by immunoassay and, in antibody-positive specimens.
Recent Stories for Education
There are several causes of kidney stones, ranging from diet to genetics. In Part 1 of this Hot Topic series, we examine the causes of stones and the need for stone analysis. Understanding the stone’s composition can support a diagnosis and help guide treatment plans and prevention options.
Follow along as we live blog the Mayo Medical Laboratories Phlebotomy 2015 Conference on April 23-24. We will be posting presentation summaries, photos and other multimedia throughout the conference. If you are on Twitter, follow the conference hashtag, which is #2015Phleb.
Other Posts for Education
- Platelet Function Tests: Precision and Reliability in Healthy Volunteers and Donors on Daily Antiplatelet Agent Therapy [Hot Topic]
- Advancements in Thyroglobulin Quantitation in the Presence of Anti-thyroglobulin Antibodies [Hot Topic]
- Seattle Children’s PLUGS Summit 2015: Ending Patient Harm & Financial Waste Associated with Mis-Ordering of Laboratory Tests
- The Importance of a Genetics Evaluation for Patients in Need of Genetic Testing
- 2015 ACMG Annual Clinical Genetics Meeting [Events]
- Phlebotomy Top Gun: Drawing Blood from a Patient Receiving Intravenous Fluids [Hot Topic]
- The Challenges of Testing For and Diagnosing Porphyrias [Communiqué]
- Register Now for Diagnostic Molecular Pathology Conference
- HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma: Indication, Interpretation, and Implication [Hot Topic]
- Measles: An Update on the Outbreak, Laboratory Testing, and Diagnosis [Hot Topic]